US 9833508
Cancer therapeutics
granted A61KA61K31/12A61K31/713
Quick answer
US patent 9833508 (Cancer therapeutics) held by IMMIX BIOPHARMA, INC. expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- IMMIX BIOPHARMA, INC.
- Grant date
- Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/12, A61K31/713, A61K39/3955, A61K47/6849